David Fitzgerald Archer MD
Reproductive Endocrinology & Infertility
Professor, Obstetrics & Gynecology, Eastern Virginia Medical School
Join to View Full Profile
601 Colley AveNorfolk, VA 23507
Phone+1 757-446-7100
Fax+1 757-446-7455
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Archer, MD is an obstetrician/gynecologist in Norfolk, Virginia. He is currently licensed to practice medicine in Virginia. He is a Professor at Eastern Virginia Medical School.
Education & Training
University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 1963 - 1966- University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 1961 - 1961
- University of Louisville School of MedicineInternship, Transitional Year, 1960 - 1961
- University of Louisville School of MedicineClass of 1960
Certifications & Licensure
VA State Medical License 1987 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Publications & Presentations
PubMed
- 3 citationsDouble dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial.Alison Edelman, Jon D Hennebold, Kise Bond, Jeong Y Lim, Ganesh Cherala
BMJ Sexual & Reproductive Health. 2025-01-06 - Prostaglandin Eregulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding.Seifeldin Sadek, Terry A Jacot, Diane M Duffy, David F Archer
F&S Science. 2024-11-01 - 5 citationsEmergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.Alison Edelman, Jeffrey T Jensen, Jill Brown, Michael Thomas, David F Archer
Contraception. 2024-09-01
Press Mentions
First Approved Vaginal Contraceptive Ring for Year-Long Use Annovera Is Proven EffectiveMarch 26th, 2019
TherapeuticsMD Presents Positive Phase 3 Data in Two Presentations for TX-001HR at ENDO 2017April 3rd, 2017- TherapeuticsMD Presents Detailed Results from Phase 3 Rejoice Trial in Postmenopausal Women with Vulvar and Vaginal Atrophy (VVA) at ENDO 2016April 2nd, 2016
Grant Support
- On Demand Oral Contraception for Obese WomenINNOVAGYN, INC.2023–2025
